Voices in Molecular Pharmaceutics: Meet Dr. Weijun Wei Who Is Developing Theranostic Nuclear Medicine Agents for Clinical Use

Mol Pharm. 2022 Oct 3;19(10):3456. doi: 10.1021/acs.molpharmaceut.2c00608. Epub 2022 Aug 4.

Author

Weijun Wei¹

Affiliation

¹ Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

PMID: 35926185
DOI: 10.1021/acs.molpharmaceut.2c00608

No abstract available

Publication types

Editorial

MeSH terms

Biopharmaceutics
Nuclear Medicine*
Precision Medicine*
Theranostic Nanomedicine